Analystreport

Syndax Pharmaceuticals (NASDAQ:SNDX) had its price target raised by analysts at UBS Group AG from $35.00 to $38.00. They now have a "buy" rating on the stock.

Syndax Pharmaceuticals, Inc.  (SNDX) 
Last syndax pharmaceuticals, inc. earnings: 3/3 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.syndax.com